Back to dashboard
CommercialPrior AuthMedium impact

Pharmacy coverage changes

Harvard Pilgrim Health Care·Endocrinology, Dermatology, Family Medicine +1 more·Pharmacy
Effective date
Jul 1, 2026
We identified it
Jun 20, 2026
Days to comply
10 days

Summary

Tufts Health plans are implementing new step therapy requirements for diabetes supplies and dermatology medications. Non-formulary continuous glucose monitors like Dexcom will require a 90-day trial of Freestyle Libre first, and Vtama cream will require a trial of Zoryve cream for plaque psoriasis.

Action Required

Before Jul 1, 2026
Before July 1, 2026: Update prior authorization procedures for Tufts Health Direct and Tufts Health RITogether plans. Providers must document 90-day Freestyle Libre trial before requesting Dexcom G6/G7 continuous glucose monitors, and document Zoryve cream trial before prescribing Vtama for plaque psoriasis. Update EMR templates to include these prerequisite trials in documentation.